Pelago receives CIR (French Research Tax Credit) accreditation

We have the pleasure to announce that the French Ministry for Higher Education and Research has recognised Pelago Bioscience AB as an approved research and development service provider. This allows companies, subject to the French General Tax Code, to take advantage of the research and development tax credit (Le Crédit d’Impôt Recherche (CIR)) available in France.

French companies which have outsourced research and development to Pelago Bioscience will be able to benefit from the research and development tax credit (Le Crédit d’Impôt Recherche (CIR)).

This approval is granted for the years: 2020, 2021, and 2022.

Are you sure?

Is you target compound really theraputic?

Speak to our experts

Learn how CETSA® can enable your project by talking to one of our Drug Discovery experts.